Your browser doesn't support javascript.
loading
Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents.
Suzuki, Kazuhiro; Yamasaki, Syudo; Miyashita, Mitsuhiro; Ando, Shuntaro; Toriumi, Kazuya; Yoshikawa, Akane; Nakanishi, Miharu; Morimoto, Yuko; Kanata, Sho; Fujikawa, Shinya; Endo, Kaori; Koike, Shinsuke; Usami, Satoshi; Itokawa, Masanari; Washizuka, Shinsuke; Hiraiwa-Hasegawa, Mariko; Meltzer, Herbert Y; Kasai, Kiyoto; Nishida, Atsushi; Arai, Makoto.
Affiliation
  • Suzuki K; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Yamasaki S; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
  • Miyashita M; Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
  • Ando S; Department of Community Mental Health, Shinshu University School of Medicine, Matsumoto, Japan.
  • Toriumi K; Research Center for Social Science & Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Yoshikawa A; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Nakanishi M; Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
  • Morimoto Y; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kanata S; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Fujikawa S; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Endo K; Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
  • Koike S; Research Center for Social Science & Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Usami S; Research Center for Social Science & Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Itokawa M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Washizuka S; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hiraiwa-Hasegawa M; Research Center for Social Science & Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Meltzer HY; University of Tokyo Institute for Diversity and Adaptation of Human Mind (UTIDAHM), University of Tokyo, Tokyo, Japan.
  • Kasai K; Center for Research and Development on Transition from Secondary to Higher Education, The University of Tokyo, Tokyo, Japan.
  • Nishida A; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Arai M; Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
Schizophrenia (Heidelb) ; 8(1): 44, 2022 Apr 27.
Article in En | MEDLINE | ID: mdl-35853893
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Schizophrenia (Heidelb) Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Schizophrenia (Heidelb) Year: 2022 Document type: Article Affiliation country: Country of publication: